UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 1, 2005
ORTHOVITA, INC.
(Exact Name of Registrant Specified in Charter)
| | | | |
| Pennsylvania | | 0-24517 | | 23-2694857 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | |
45 Great Valley Parkway Malvern, Pennsylvania | | 19355 |
| (Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone, including area code: (610) 640-1775
Not applicable.
(Former Name and Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 Entry Into Material Definitive Agreement.
Effective August 1, 2005, the Board of Directors (the “Board”) of Orthovita, Inc. approved an amendment to its existing compensation policy with respect to members of the Board who are not employees and who undertake projects on behalf of the Board or a committee thereof that are in furtherance of the duties and obligations of the Board or such committee. The amendment provides that any member undertaking such project shall receive an amount equal to the fee paid by the Company for attendance in person at meetings of the Board, as well as reimbursement for all out-of-pocket expenses incurred by the Board member on behalf of the Company consistent with the Company’s existing expense reimbursement policies. The current fees paid by the Company to members of the Board for attendance in person at meetings of the Board is set forth in the Company’s Proxy Statement for the 2005 Annual Meeting of Shareholders.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| ORTHOVITA, INC. |
| |
| By: | | /s/ Joseph M. Paiva
|
| | | Joseph M. Paiva |
| | | Chief Financial Officer |
Dated: August 4, 2005
